EP0941111A4 - Wachstumsfaktor-antagonisten von hepatozyten - Google Patents

Wachstumsfaktor-antagonisten von hepatozyten

Info

Publication number
EP0941111A4
EP0941111A4 EP97948148A EP97948148A EP0941111A4 EP 0941111 A4 EP0941111 A4 EP 0941111A4 EP 97948148 A EP97948148 A EP 97948148A EP 97948148 A EP97948148 A EP 97948148A EP 0941111 A4 EP0941111 A4 EP 0941111A4
Authority
EP
European Patent Office
Prior art keywords
growth factor
hepatocyte growth
factor antagonists
antagonists
hepatocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97948148A
Other languages
English (en)
French (fr)
Other versions
EP0941111A1 (de
Inventor
David Patrick Brooks
Nicholas James Laping
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0941111A1 publication Critical patent/EP0941111A1/de
Publication of EP0941111A4 publication Critical patent/EP0941111A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP97948148A 1996-11-05 1997-11-03 Wachstumsfaktor-antagonisten von hepatozyten Withdrawn EP0941111A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3034296P 1996-11-05 1996-11-05
US30342P 1996-11-05
PCT/US1997/019891 WO1998019696A1 (en) 1996-11-05 1997-11-03 Hepatocyte growth factor antagonists

Publications (2)

Publication Number Publication Date
EP0941111A1 EP0941111A1 (de) 1999-09-15
EP0941111A4 true EP0941111A4 (de) 2000-09-27

Family

ID=21853771

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97948148A Withdrawn EP0941111A4 (de) 1996-11-05 1997-11-03 Wachstumsfaktor-antagonisten von hepatozyten

Country Status (4)

Country Link
EP (1) EP0941111A4 (de)
JP (1) JP2001505995A (de)
CA (1) CA2270867A1 (de)
WO (1) WO1998019696A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034650A1 (en) * 1999-11-09 2001-05-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Heatlh And Human Services Hgf-sf monoclonal antibody combinations
US20030118585A1 (en) 2001-10-17 2003-06-26 Agy Therapeutics Use of protein biomolecular targets in the treatment and visualization of brain tumors
CN103880955A (zh) 2003-07-18 2014-06-25 安姆根有限公司 肝细胞生长因子的特异性结合物
JP5222720B2 (ja) 2005-04-15 2013-06-26 ジェネンテック， インコーポレイテッド ＨＧＦβ鎖変異体

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005184A1 (en) * 1990-09-14 1992-04-02 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce A non-mitogenic competitive hgf antagonist
WO1994006909A2 (en) * 1992-09-18 1994-03-31 United States Of America, As Represented By The Secretary, Department Of Health And Human Services A method of preventing tumor metastasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023541A1 (en) * 1992-05-18 1993-11-25 Genentech, Inc. Hepatocyte growth factor variants
US5646036A (en) * 1995-06-02 1997-07-08 Genentech, Inc. Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005184A1 (en) * 1990-09-14 1992-04-02 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce A non-mitogenic competitive hgf antagonist
WO1994006909A2 (en) * 1992-09-18 1994-03-31 United States Of America, As Represented By The Secretary, Department Of Health And Human Services A method of preventing tumor metastasis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BORDER W A ET AL: "SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINSTTRANSFORMING GROWTH FACTOR BETA1", NATURE, 26 July 1990 (1990-07-26), XP002025313 *
KOLATSI-JOANNOU MARIA ET AL: "The hepatocyte growth factor/scatter factor (HGF/SF) receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells.", JOURNAL OF CELL SCIENCE, vol. 108, no. 12, 1995, pages 3703 - 3714, XP002143658, ISSN: 0021-9533 *
See also references of WO9819696A1 *

Also Published As

Publication number Publication date
WO1998019696A1 (en) 1998-05-14
JP2001505995A (ja) 2001-05-08
EP0941111A1 (de) 1999-09-15
CA2270867A1 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
IL118476A0 (en) Hepatocyte growth factor receptor antagonists and uses thereof
EP0946164A4 (de) Integrin antagonisten
HU9700328D0 (en) New heteroaryl-oxazolidinones
GB2320169B (en) Network configuration
EP0913191A4 (de) Mikroemulsion
EP0874563A4 (de) Hängevorrichtung zur Befestigung an einer Tischkante
HUP9702167A3 (en) Ceramic glowplug
HUP0102821A3 (en) Neurotrophic growth factor
EP0904292A4 (de) Wachstums-differenzierungsfaktor-14
HU9503191D0 (en) Adhesion-receptor antagonists
EP0941111A4 (de) Wachstumsfaktor-antagonisten von hepatozyten
GB2319863B (en) Groupware
GB2315286B (en) Structure
EP1005489A4 (de) Neue polypeptide aus der wachstumsfaktorfamilie
EP0891372A4 (de) Wachstumfaktor httr36
GB9616786D0 (en) Catch
GB9619489D0 (en) Growth factors
GB9719794D0 (en) Growth Factors
TW299567U (en) Artificial snake-wood structure
AU129452S (en) Pillowcase
GB9601419D0 (en) Letterbox
PL313215A1 (en) Fibre-cement composition
PL315314A1 (en) Low density concrete
TW301187U (en) Hanger structure
GB9619966D0 (en) Coat-hanger securing rail

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990512

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IT LI NL

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 38/18 A, 7G 01N 33/53 B, 7C 12Q 1/68 B

A4 Supplementary search report drawn up and despatched

Effective date: 20000810

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE ES FR GB IT LI NL

17Q First examination report despatched

Effective date: 20010606

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20011017

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1022637

Country of ref document: HK